-
New statistics detail the nation’s worsening tide of sexually transmitted infections, but health officials are hoping an old drug will help the fight.
-
The new study targets redfish found in waters from St. Augustine to Pensacola and builds on a similar survey released last year that also found bonefish contaminated with pharmaceuticals in the Keys and Biscayne Bay.
-
Doctors have no national standards on when to order urine tests to check whether adult ADHD patients are properly taking their medication. Some patients are subjected to much more frequent testing than others.
-
The Senate Health Policy Committee approved the bill, while the House Healthcare Regulation Subcommittee is slated to take up its version on Tuesday.
-
Drugmakers long ceased to be the only villain of the insulin price scandal. While Lilly is cutting the list price and others may follow, will other "parties" (i.e. pharmacy benefit managers) cause the cost to increase before it hits the pharmacy counter?
-
The moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live.
-
The billionaire entrepreneur, Dallas Mavericks owner and "Shark Tank" star is making waves with his new drug company. But his generics aren’t always the lowest-priced deal.
-
Patients who depend upon special drugs to treat rare diseases are caught in the crossfire as drugmakers and the FDA battle over regulations that reward companies for developing treatments for relatively small pools of patients.
-
Twitter has been a hotbed for the insulin access movement and activism surrounding other medical conditions - helping propel concern about the prices into policy. Can it continue to win with hashtags?
-
Increasingly, the FDA is asking drugmakers to remove unproven uses from older drugs that haven't delivered on early results. And drugmakers seeking accelerated approvals are facing tougher hurdles.
-
Since pharmaceutical companies started funding their FDA drug applications 30 years ago, the agency’s reviews have gone much faster — perhaps too fast.
-
Approved as a device, not a drug, Plenity contains a plant-based gel that swells to fill 25% of a person’s stomach, to help people eat less. Results vary widely but are modest on average.